ILT-101 liquide, Placebo of ILT-101
APHP230867
Phase 2 small_molecule active
Quick answer
ILT-101 liquide, Placebo of ILT-101 for Autism Spectrum disorder ASD is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Autism Spectrum disorder ASD
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active